In most cases, children with idiopathic nephrotic syndrome (INS) are first treated with prednisolone according to the International Study of Kidney Disease in Children (ISKDC) induction protocol (prednisolone at 60 mg/m
2/day for 4 weeks, followed by 40 mg/m
2/day for 4 weeks). Steroid sensitive nephrotic syndrome (SSNS) is experienced by approximately 90 percent of all patients with INS. We conducted a retrospective analysis of the association between duration of the steroid therapy until the first remission, relapse occurrence in a two year period following the remission and early-stage relapse within six months following the remission. Twenty five patients with SSNS having two or more years of treatment history were enrolled in our study, who were initially treated with prednisolone according to the ISKDC induction protocol, achieved remission within 4 weeks and were able to stop prednisolone therapy in 8 weeks from the start of the steroid therapy. Receiver operating characteristic (ROC) analysis of the association between duration before the first remission and progression to steroid dependent nephrotic syndrome (SDNS) was statistically significant (p=0.027). The best cut-off value was eight days with a sensitivity of 75.0% and a specificity of 76.5%. Fifteen patients achieved remission within 7 days (early remission group) and 10 patients required 8 or more days to achieve remission (remission group). Significantly fewer patients in the early remission group developed to SDNS within two years following the first remission compared to the remission group (13% vs. 60%; p=0.014, χ
2 test). No significant difference was seen between the duration of the steroid therapy until the first remission and an early-stage relapse (27% vs. 50%; p=0.234, χ
2 test). Guidelines outlining standardized early-stage indicators for steroid dependency of patients with SSNS are not yet to be established, but several studies have reported the association between the duration of the initial steroid therapy until remission and the possibility of steroid dependency. The results of our study showed that the duration of the initial steroid therapy until remission could be an useful early-stage indicator for long-term steroid dependency of patients with SSNS. If we stratify the risk of patients with SSNS according to the duration needed to achieve the first remission and organize treatment protocol according to the risk stratification, we may be able to improve the treatment outcome of SSNS.
View full abstract